Home Institutions MD Anderson Cancer Center clinical trials Institution Directory
Clinical trials at MD Anderson Cancer Center Sites in Houston, TX
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:14 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
2395
Current sort
Recently updated
Campus scope
MD Anderson Cancer Center, Houston, TX
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 433–444 of 2,395 matching trials with a site at MD Anderson Cancer Center, Houston, TX.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Multiple Myeloma
Interventions Arlocabtagene Autoleucel Biological
Lead sponsor Juno Therapeutics, Inc., a Bristol-Myers Squibb Company Industry
Eligibility 18 Years and older
Enrollment 230 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2032
U.S. locations 41
States / cities Birmingham, Alabama • Gilbert, Arizona • Little Rock, Arkansas + 33 more
Conditions Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma
Interventions Radiation Therapy, Temozolomide, Veliparib Radiation · Drug
Lead sponsor Children's Oncology Group Network
Eligibility 3 Years to 25 Years
Enrollment 38 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2018 – 2027
U.S. locations 145
States / cities Birmingham, Alabama • Mobile, Alabama • Mesa, Arizona + 111 more
Conditions Malignant Neoplasms of Respiratory and Intrathoracic Organs, Squamous Cell Carcinoma of the Larynx
Interventions Stereotactic Hypofractionated Radioablation, Questionnaires Radiation · Behavioral
Lead sponsor M.D. Anderson Cancer Center Other
Eligibility 18 Years and older
Enrollment 11 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2017 – 2027
U.S. locations 1
States / cities Houston, Texas
Conditions Solid Tumors
Interventions BMS-986504, Daraxonrasib, Nivolumab + Relatlimab FDC, Temozolomide, Pumitamig, Pemetrexed, Carboplatin, Nab-paclitaxel, Gemcitabine, Paclitaxel Drug
Lead sponsor Bristol-Myers Squibb Industry
Eligibility 18 Years and older
Enrollment 260 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2032
U.S. locations 16
States / cities San Francisco, California • Aurora, Colorado • Atlanta, Georgia + 10 more
Conditions Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Interventions TAS6417, CYP Cocktail, Transporter Cocktail Drug
Lead sponsor Taiho Oncology, Inc. Industry
Eligibility 18 Years and older
Enrollment 220 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2028
U.S. locations 18
States / cities Birmingham, Alabama • Duarte, California • Boston, Massachusetts + 15 more
Conditions Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Solid Neoplasm
Interventions Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18 Fluorthanatrace, Positron Emission Tomography Procedure · Radiation
Lead sponsor M.D. Anderson Cancer Center Other
Eligibility 18 Years and older · Female only
Enrollment 300 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2018 – 2027
U.S. locations 1
States / cities Houston, Texas
Conditions Acute Myeloid Leukemia, Myelodysplastic Syndrome
Interventions Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan, Cladribine, Fludarabine Phosphate, Laboratory Biomarker Analysis, Peripheral Blood Stem Cell Transplantation, Pharmacological Study, Venetoclax Procedure · Drug · Other
Lead sponsor M.D. Anderson Cancer Center Other
Eligibility 2 Years to 70 Years
Enrollment 116 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2014 – 2027
U.S. locations 1
States / cities Houston, Texas
Conditions Malignant Neoplasm
Interventions Patritumab Deruxtecan Biological
Lead sponsor Merck Sharp & Dohme LLC Industry
Eligibility 1 Month to 17 Years
Enrollment 50 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2030
U.S. locations 17
States / cities Los Angeles, California • Aurora, Colorado • New Haven, Connecticut + 14 more
Conditions Metastatic Malignancy
Interventions Atezolizumab, Tiragolumab Drug
Lead sponsor M.D. Anderson Cancer Center Other
Eligibility 18 Years and older
Enrollment 10 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2028
U.S. locations 1
States / cities Houston, Texas
Conditions Cancer, Occupational Therapy
Interventions Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Other
Lead sponsor M.D. Anderson Cancer Center Other
Eligibility 18 Years and older
Enrollment 80 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2027
U.S. locations 1
States / cities Houston, Texas
Conditions Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8
Interventions Atezolizumab, Biospecimen Collection, Computed Tomography, Fludeoxyglucose F-18, Positron Emission Tomography, Quality-of-Life Assessment, Questionnaire Administration, Stereotactic Body Radiation Therapy Drug · Procedure · Other + 1 more
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 417 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 391
States / cities Anchorage, Alaska • Jonesboro, Arkansas • Little Rock, Arkansas + 291 more
Conditions Breast Carcinoma
Interventions Electronic Health Record Review Other
Lead sponsor M.D. Anderson Cancer Center Other
Eligibility 18 Years and older · Female only
Enrollment 750 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2026
U.S. locations 1
States / cities Houston, Texas About this MD Anderson Cancer Center institution page
What this page lists ClinicalTrials.gov records that list MD Anderson Cancer Center in Houston, TX as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , trials led by M.D. Anderson Cancer Center at any site , browse by condition , or browse by U.S. city .